Gupta R P, Perez-Padilla R, Marks G, Vollmer W, Menezes A, Burney P
Respiratory Epidemiology and Public Health, National Heart and Lung Institute, Imperial College, London, UK.
Instituto Nacional de Enfermedades Respiratorias, Mexico City, Mexico.
Int J Tuberc Lung Dis. 2014 Aug;18(8):998-1003. doi: 10.5588/ijtld.13.0910.
The use of different spirometric definitions for chronic obstructive pulmonary disease (COPD) has made an informative review of the available prevalence surveys impossible.
To derive adjustment factors that allow the comparison of studies using different spirometric criteria.
Pre- and post-bronchodilator one-second forced expiratory volume (FEV1) and forced vital capacity (FVC) values were taken from the Burden of Obstructive Lung Disease (BOLD) survey in 16 centres. Using a post-bronchodilator FEV1/FVC ratio less than the lower limit of normal (LLN) as our reference prevalence, we calculated simple multiplicative adjustments to transform other reported prevalence estimates to reference values. These adjustments were then tested on independent data sets from six further BOLD centres and five centres from the PLATINO study, a Latin American survey on obstructive lung disease.
Prevalence estimates based on pre-bronchodilator fixed-ratio measurements were 5-25% higher than reference values, and were strongly positively biased with age and prevalence level. Applying simple adjustments provided prevalence estimates that were almost unbiased and within 5% of the reference values.
Using the BOLD data, we have been able to estimate COPD prevalences based on post-bronchodilator FEV1/FVC < LLN by adjusting estimates based on other common definitions, enabling more meaningful comparisons of published findings.
对慢性阻塞性肺疾病(COPD)使用不同的肺量计定义使得对现有患病率调查进行信息丰富的综述变得不可能。
得出调整因子,以便能够对使用不同肺量计标准的研究进行比较。
支气管扩张剂使用前后的一秒用力呼气容积(FEV1)和用力肺活量(FVC)值取自16个中心的慢性阻塞性肺疾病负担(BOLD)调查。以支气管扩张剂使用后FEV1/FVC比值低于正常下限(LLN)作为我们的参考患病率,我们计算了简单的乘法调整,以将其他报告的患病率估计值转换为参考值。然后在另外六个BOLD中心和拉丁美洲阻塞性肺疾病调查PLATINO研究的五个中心的独立数据集中对这些调整进行测试。
基于支气管扩张剂使用前固定比值测量的患病率估计值比参考值高5%-25%,并且与年龄和患病率水平呈强烈正偏差。应用简单调整后得出的患病率估计值几乎无偏差,且在参考值的5%以内。
利用BOLD数据,我们能够通过调整基于其他常见定义的估计值,基于支气管扩张剂使用后FEV1/FVC<LLN来估计COPD患病率,从而使已发表研究结果的比较更有意义。